Ofev (nintedanib) - Risk Of Drug-induced Liver Injury And The Need For Regular Monitoring Of Liver Function

OFEV Recall Summary OFEV (nintedanib) carries a risk of drug-induced liver injury, and patients taking this medication need to have their liver function monitored regularly. This recall applies to OFEV distributed across Canada. The medication is used to treat certain lung conditions.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2018-01-11

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/09035c35-dd3d-4e23-b4a0-2913d979b2b1